129 related articles for article (PubMed ID: 16428039)
21. Editorial: Resecting or burning: what should we do with the remaining barrett's epithelium after successful ER of neoplasia?
Pech O; Ell C
Am J Gastroenterol; 2009 Nov; 104(11):2693-4. PubMed ID: 19888235
[TBL] [Abstract][Full Text] [Related]
22. Esophageal polypoid dysplasia of gastric foveolar phenotype with focal intramucosal carcinoma associated with Barrett's esophagus.
Asthana N; Mandich D; Ligato S
Am J Surg Pathol; 2008 Oct; 32(10):1581-5. PubMed ID: 18724240
[TBL] [Abstract][Full Text] [Related]
23. Activation of Akt is increased in the dysplasia-carcinoma sequence in Barrett's oesophagus and contributes to increased proliferation and inhibition of apoptosis: a histopathological and functional study.
Beales IL; Ogunwobi O; Cameron E; El-Amin K; Mutungi G; Wilkinson M
BMC Cancer; 2007 Jun; 7():97. PubMed ID: 17559672
[TBL] [Abstract][Full Text] [Related]
24. Esophagectomy for clinical high-grade dysplasia.
Rice TW; Murthy SC; Mason DP; Rybicki LA; Yerian LM; Dumot JA; Rodriguez CP; Blackstone EH
Eur J Cardiothorac Surg; 2011 Jul; 40(1):113-9. PubMed ID: 21277216
[TBL] [Abstract][Full Text] [Related]
25. Is the risk of concomitant invasive esophageal cancer in high-grade dysplasia in Barrett's esophagus overestimated?
Konda VJ; Ross AS; Ferguson MK; Hart JA; Lin S; Naylor K; Noffsinger A; Posner MC; Dye C; Cislo B; Stearns L; Waxman I
Clin Gastroenterol Hepatol; 2008 Feb; 6(2):159-64. PubMed ID: 18096439
[TBL] [Abstract][Full Text] [Related]
26. Endoscopic surveillance in Barrett's esophagus.
Lunedei V; Bazzoli F; Pozzato P; De Luca L; Zagari RM; Fossi S; Ricciardiello L; Maltoni S; Roda E
Minerva Gastroenterol Dietol; 2002 Jun; 48(2):63-71. PubMed ID: 16489297
[TBL] [Abstract][Full Text] [Related]
27. Surveillance in Barrett's oesophagus: will a strategy focused on a high-risk group reduce mortality from oesophageal adenocarcinoma?
Quera R; O'Sullivan K; Quigley EM
Endoscopy; 2006 Feb; 38(2):162-9. PubMed ID: 16479424
[TBL] [Abstract][Full Text] [Related]
28. [Polymorphism/loss of heterozygosity of APC gene in GERD-Barrett's metaplasia-dysplasia-adenocarcinoma sequence].
Mokrowiecka A; Wierzchniewska-Ławska A; Smolarz B; Romanowicz-Makowska H; Malecka-Panas E
Pol Merkur Lekarski; 2009 May; 26(155):385-9. PubMed ID: 19606680
[TBL] [Abstract][Full Text] [Related]
29. An open-label, prospective trial of cryospray ablation for Barrett's esophagus high-grade dysplasia and early esophageal cancer in high-risk patients.
Dumot JA; Vargo JJ; Falk GW; Frey L; Lopez R; Rice TW
Gastrointest Endosc; 2009 Oct; 70(4):635-44. PubMed ID: 19559428
[TBL] [Abstract][Full Text] [Related]
30. Endoscopic therapy in Barrett's esophagus: when and how?
Spechler SJ; Davila R
Surg Oncol Clin N Am; 2009 Jul; 18(3):509-21. PubMed ID: 19500740
[TBL] [Abstract][Full Text] [Related]
31. Extent of low-grade dysplasia is a risk factor for the development of esophageal adenocarcinoma in Barrett's esophagus.
Srivastava A; Hornick JL; Li X; Blount PL; Sanchez CA; Cowan DS; Ayub K; Maley CC; Reid BJ; Odze RD
Am J Gastroenterol; 2007 Mar; 102(3):483-93; quiz 694. PubMed ID: 17338734
[TBL] [Abstract][Full Text] [Related]
32. Five-year efficacy and safety of photodynamic therapy with Photofrin in Barrett's high-grade dysplasia.
Overholt BF; Wang KK; Burdick JS; Lightdale CJ; Kimmey M; Nava HR; Sivak MV; Nishioka N; Barr H; Marcon N; Pedrosa M; Bronner MP; Grace M; Depot M;
Gastrointest Endosc; 2007 Sep; 66(3):460-8. PubMed ID: 17643436
[TBL] [Abstract][Full Text] [Related]
33. Outcomes and health-related quality of life after esophagectomy for high-grade dysplasia and intramucosal cancer.
Moraca RJ; Low DE
Arch Surg; 2006 Jun; 141(6):545-9; discussion 549-51. PubMed ID: 16785354
[TBL] [Abstract][Full Text] [Related]
34. [Extent of lymphnode dissection with minimally invasive esophageal resection].
Böttger T; Terzic A; Müller M
Zentralbl Chir; 2006 Dec; 131(6):466-73. PubMed ID: 17206565
[TBL] [Abstract][Full Text] [Related]
35. [Gastroesophageal reflux disease and malignancy].
Richert Z; Robaszkiewicz M
Rev Prat; 2008 Sep; 58(13):1414-5, 1417, 1419-20. PubMed ID: 18924321
[TBL] [Abstract][Full Text] [Related]
36. A New Horizon: Recommendations and Treatment Guidelines for Barrett's Esophagus.
Gastroenterol Nurs; 2009; 32(3):211-2. PubMed ID: 19506438
[No Abstract] [Full Text] [Related]
37. Minimally invasive esophagectomy for malignant and premalignant diseases of the esophagus.
Maloney JD; Weigel TL
Surg Clin North Am; 2008 Oct; 88(5):979-90, vi. PubMed ID: 18790149
[TBL] [Abstract][Full Text] [Related]
38. Non-biopsy detection of intestinal metaplasia and dysplasia in Barrett's esophagus: a prospective multicenter study.
Sharma P; Marcon N; Wani S; Bansal A; Mathur S; Sampliner R; Lightdale C
Endoscopy; 2006 Dec; 38(12):1206-12. PubMed ID: 17163320
[TBL] [Abstract][Full Text] [Related]
39. Squamous dysplasia and other precursor lesions related to esophageal squamous cell carcinoma.
Shimizu M; Ban S; Odze RD
Gastroenterol Clin North Am; 2007 Dec; 36(4):797-811, v-vi. PubMed ID: 17996791
[TBL] [Abstract][Full Text] [Related]
40. Is there an advantage to be gained from adding digital image cytometry of brush cytology to a standard biopsy protocol in patients with Barrett's esophagus?
Borovicka J; Schönegg R; Hell M; Kradolfer D; Bauerfeind P; Dorta G; Netzer P; Binek J; Meyenberger C; Fischer JE; Spieler P
Endoscopy; 2009 May; 41(5):409-14. PubMed ID: 19418394
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
